APA (7th ed.) Citation

Saito, T., Ishida, M., Akama, T. O., Hattori, S., Maru, N., Utsumi, T., . . . Murakawa, T. (2025). Clinical and pathological implications of the presence of MECA-79-expressing tumor cells in pathological stage IA lung adenocarcinoma. PLoS ONE, 20(10), 1. https://doi.org/10.1371/journal.pone.0323233

Chicago Style (17th ed.) Citation

Saito, Tomohito, et al. "Clinical and Pathological Implications of the Presence of MECA-79-expressing Tumor Cells in Pathological Stage IA Lung Adenocarcinoma." PLoS ONE 20, no. 10 (2025): 1. https://doi.org/10.1371/journal.pone.0323233.

MLA (9th ed.) Citation

Saito, Tomohito, et al. "Clinical and Pathological Implications of the Presence of MECA-79-expressing Tumor Cells in Pathological Stage IA Lung Adenocarcinoma." PLoS ONE, vol. 20, no. 10, 2025, p. 1, https://doi.org/10.1371/journal.pone.0323233.